Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.39
-0.1400-0.28%
Volume:244.63K
Turnover:12.16M
Market Cap:3.90B
PE:-10.45
High:50.31
Open:50.25
Low:49.11
Close:49.53
Loading ...
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities